SHAREHOLDERS in the biopharmaceutical company Renovo have been advised to abstain from approving a remuneration report which it is claimed could lead to executives taking "risky decisions".
Governance watchdog Pensions Investments Research Consultants is concerned over a resolution to increase the maximum award available under the firm’s long term incentive scheme. PIRC are also co...
To continue reading this article...
Join Professional Pensions
- Unlimited access to real-time news, analysis and opinion from the industry
- Receive our in-depth monthly magazine in either print or digital format
- Access our Sustainable Investment Hub covering news and opinion from thought leaders in the ESG space
- Receive important and breaking news stories selected by the Editors in our daily newsletter
- Hear from industry experts and other forward-thinking leaders
- Receive a monthly members-only newsletter with exclusive opinion pieces from leading industry experts and a feature from the magazine in advance of its release date